No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
AVDL240816C17500
- 0.82
- +0.17+26.15%
15min DelayClose Jul 22 15:59 ET
0.82High0.65Low
0.65Open0.65Pre Close108 Volume771 Open Interest17.50Strike Price7.43KTurnover66.66%IV11.23%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier24DDays to Expiry0.82Extrinsic Value100Contract SizeAmericanOptions Type0.4041Delta0.1356Gamma21.96Leverage Ratio-0.0234Theta0.0040Rho8.87Eff Leverage0.0166Vega
Intraday
- 5D
- Daily
News
Avadel Pharmaceuticals Plc's (NASDAQ:AVDL) Path To Profitability
Oppenheimer's Top SMID Ideas Within High-growth Themes
Avadel Pharmaceuticals to Join Russell 3000 Index
Oppenheimer Maintains Avadel Pharmaceuticals(AVDL.US) With Buy Rating, Maintains Target Price $29
Rodman & Renshaw Initiates Avadel Pharmaceuticals(AVDL.US) With Buy Rating, Announces Target Price $27
European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading
Comments
The recent sale from a key insider at the current share price of US$14.12 raises concerns, despite insiders holding sizable shares in the company. This trend combined with limited recent insider buying causes a cautious outlook towards the company's stock.
$Avadel Pharmaceuticals(AVDL.US$
helloooooo dippy. should run rest of day. 👍🏻
Enjoy your Veterans day and have a blessed weekend.
helloooooo dippy. should run rest of day. 👍🏻
Enjoy your Veterans day and have a blessed weekend.
1
Insider sales surpassed insider buying at Avadel Pharmaceuticals in recent months, but yearly transactions are positive. Insider ownership aligns with shareholders, with recent sales not raising major concerns.
1
1
Read more